Momentum Stocks Decoded: Why Belden Stands Out While ZoomInfo and Azenta Raise Red Flags

Three Hot Momentum Stocks — But Not All Are Created Equal

A surge in share price can generate plenty of investor excitement, but momentum alone rarely tells the whole story. Three stocks — Belden (NYSE: BDC), ZoomInfo (NASDAQ: GTM), and Azenta (NASDAQ: AZTA) — have each posted strong one-month gains as of mid-August 2026, yet their underlying fundamentals paint very different pictures for those with a longer-term horizon.

Belden: The Standout Performer

Belden, a manufacturer of electronic components with a history stretching back to World War I — when its enamel-coated copper wire was used by Allied forces — has delivered the strongest momentum of the three, climbing 30.1% over the past month. But unlike many momentum plays, the numbers beneath the surface appear to support the rally.

Revenue has expanded at an annual rate of 11.2% over the past two years, suggesting the company has been capturing meaningful market share. Looking ahead, analysts project revenue growth of 34.6% over the next 12 months — a figure that actually exceeds the company's recent two-year trend, pointing to what could be accelerating demand across the industries it serves.

Shareholder returns have also benefited from an active buyback program. Belden's earnings per share grew at an annual rate of 16.7% over the last two years, outpacing revenue growth — a dynamic that typically signals effective capital allocation. At its current share price of $129.49, the stock trades at 14.9x forward price-to-earnings, a relatively modest multiple given the projected growth trajectory.

ZoomInfo: Momentum Masking Fundamental Weakness?

ZoomInfo, which markets an AI-driven platform it calls "RevOS" (Revenue Operating System) designed to help sales, marketing, and recruiting teams identify prospects and execute targeted outreach, has gained 23.4% over the past month. However, several underlying metrics give analysts reason for caution.

Billings have plateaued over the past year, suggesting customers are hesitating before committing to multi-year contracts on the platform. More concerning, revenue is projected to decline by 6.2% over the next 12 months — a significant reversal for a company that once commanded premium growth expectations. Operating margins have also compressed sharply, falling by 49.7 percentage points over the last year, raising questions about the sustainability of the business model at its current scale.

At $3.86 per share, ZoomInfo trades at 0.9x forward price-to-sales — a valuation that reflects the market's skepticism but may not fully account for the pace of deterioration in key operating metrics.

Azenta: Long-Term Structural Challenges Persist

Azenta, a specialist in biological sample management, storage, and genomic services catering to pharmaceutical and biotechnology companies, has surged 25.8% over the past month. The company plays an important role in preserving critical research materials, but its financial trajectory has been moving in the wrong direction.

Revenue has contracted at an average annual rate of 3.5% over the past two years, indicating that customers have been delaying or reducing their purchasing commitments. The earnings picture is even more concerning over a longer timeframe: earnings per share have declined at an annual rate of 28.6% over the past five years, a trend that tends to weigh heavily on stock valuations over time. Additionally, negative free cash flow raises questions about how efficiently the company is converting its investments into returns.

Azenta currently trades at $33.02 per share, implying a forward price-to-earnings ratio of 58.2x — a premium multiple that appears difficult to justify given the current earnings trajectory.

What Investors Should Watch

Momentum investing can produce outsized short-term gains, but history shows it can also lead to painful reversals when the underlying fundamentals don't support elevated valuations. The divergence between these three stocks illustrates that point clearly.

For Belden, the combination of accelerating revenue growth, expanding earnings per share, and a reasonable valuation multiple makes its recent rally appear more grounded in business performance. For ZoomInfo and Azenta, the sharp price moves over the past month come against a backdrop of weakening financial metrics — a combination that has historically proven difficult to sustain.

As always, investors should conduct thorough due diligence and consider how each company's fundamentals align with their own investment objectives and risk tolerance before making any portfolio decisions.